Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
10.1002/bab.1319 160 SpinelliM.FuscoS.GrassiC
Our mission is simple: to make trusted weight loss care available to everyone from the comfort of home
, ,
If you want to choose from multiple pharmacies and formulations, Lavender Sky offers more flexibility
At 48 weeks, of people given 8 mg, 100% lost 5%+, 91% lost 10%+, and 75% lost 15%+
Failed Attempts: Multiple drugs (Selonsertib, Cenicriviroc, Elafibranor) failed Phase 3 NASH trials because they: Targeted single pathways (inflammation or fibrosis) Didn't address root cause (obesity, insulin resistance) Showed biomarker improvements but not biopsy-proven NASH resolution Retatrutide's Advantage: Addresses root metabolic dysfunction (28.7% weight loss) Proven up to 82.4% liver fat reduction (Phase 2a) Inflammation resolution (enzyme normalization) Multi-pathway hepatic benefits Probability of Success: Higher than previous NASH drug candidates, but biopsy-proven efficacy still needs confirmation
US$ 20.40
US$ 27.38
US$ 29.87
US$ 24.88
US$ 20.32
US$ 29.01
